Gemcitabine and Its Combinations in the Treatment of Malignant Lymphoma-Reference-Cited by-同舟云学术

Gemcitabine and Its Combinations in the Treatment of Malignant Lymphoma

Published:2002-09 Issue:2 Volume:3 Page:97-104
ISSN:1526-9655
Container-title:Clinical Lymphoma
language:en
Short-container-title:Clinical Lymphoma

Author:

Chau Ian,Watkins David,Cunningham David

Publisher

Elsevier BV

Subject

Cancer Research

Reference77 articles.

1. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD;Canellos;N Engl J Med,1992

2. Long-term follow-up of Hodgkin's disease trial;Canellos;N Engl J Med,2002

3. Treatment of relapsed Hodgkin's disease: strategies and prognostic factors;Canellos;Ann Oncol,1998

4. Problems in Hodgkin's disease management;Aisenberg;Blood,1999

5. BEACOPP chemotherapy with dose escalation in advanced Hodgkin's disease: Final analysis of the German Hodgkin lymphoma study group HD9 randomized trial;Diehl;Blood,2001

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on nasal natural killer/T-cell lymphoma;International Immunopharmacology;2021-09

2. Pixantrone–rituximab versus gemcitabine–rituximab in relapsed/refractory aggressive non-Hodgkin lymphoma;Future Oncology;2016-08

3. Synergistic Antitumor Activity of Anti-CD25 Recombinant Immunotoxin LMB-2 with Chemotherapy;Clinical Cancer Research;2011-11-08

4. HDM-2 inhibition suppresses expression of ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine-induced cytotoxicity in mantle cell lymphoma;Blood;2011-10-13

5. Small-Animal PET/CT for Monitoring the Development and Response to Chemotherapy of Thymic Lymphoma in Trp53−/− Mice;Journal of Nuclear Medicine;2010-07-21